Linked Data API

Show Search Form

Search Results

1039028
star this property registered interest false more like this
star this property date less than 2019-01-10more like thismore than 2019-01-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Asparaginase more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether Erwinase will be available for the treatment for children with acute lymphoblastic leukaemia between January 2019 and March 2019; and if he will make a statement. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 207238 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-01-18more like thismore than 2019-01-18
star this property answer text <p>Erwinase is produced by Porton Biopharma Ltd (PBL) and is licensed and distributed by Jazz Pharmaceuticals under a global licencing agreement.</p><p> </p><p>Due to increased demand for Erwinase and because PBL are manufacturing at capacity, until increases in capacity are brought into beneficial use there will be occasional stock-outs.</p><p> </p><p>The product is currently in stock in the United Kingdom. The Department has been informed, it is likely there will be a short stock-out in early February 2019 and then a further batch is planned to be released to Jazz Pharmaceuticals, who are responsible for the packaging/distribution and allocation of worldwide product supply, anticipated to reach the UK market by mid-February 2019 which should last until the end of March 2019.</p><p> </p><p>The Department and Public Health England (PHE) are in close contact with, and have been kept informed by the PBL management of short periods of interrupted supply. PBL have and will be implementing a series of initiatives to increase capacity and better supply the market in both the short and long term. PBL are fully aware of the consequences that the unavailability of Erwinase has on patients and are absolutely committed to working with all involved to resolve any issues and be able to supply this critical medicine.</p><p> </p><p>The Department and PHE will continue to monitor the situation closely.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-18T12:18:00.113Zmore like thismore than 2019-01-18T12:18:00.113Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1050101
star this property registered interest false more like this
star this property date less than 2019-01-28more like thismore than 2019-01-28
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Asparaginase more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207238 on Asparaginase, what steps Porton Biopharma will take to increase capacity of erwinase and better supply the (a) UK and (b) world market for the remainder of 2019. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 213322 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-05more like thismore than 2019-02-05
star this property answer text <p>Porton Biopharma Ltd (PBL) are implementing a series of initiatives to increase capacity and supply in both the short and long term. These include the following:</p><p>- Extending operational activities to 24 hours a day, seven days a week to maximise fermentation of the product;</p><p>- Implementing an ongoing capital programme including construction of a new pharmaceutical fermentation facility. The facility was completed in April 2018 and is currently undergoing testing; it has an increased capacity fermentation suite which will enable PBL to manufacture at larger scale and is due to start producing product Q3 2019 for regulatory approval to market;</p><p>- A new filling and freeze-drying building was completed in February 2016. The installation of a new filling line which covers the entire process, including vial washing, filling, stoppering and freeze drying. The new line has been designed with systems which monitor all critical parameters throughout the process to accelerate batch release and will accommodate increased capacity. The beneficial use of this and the fermentation facility will coincide to maximise increased product output; and</p><p>- Sourcing replacement suppliers, including for new stoppers and new vials for the product, ensuring that maximum batch sizes can be achieved with minimal product rejects. This programme is complete.</p><p> </p><p>PBL has made significant investments into increasing product capacity and will continue to release future batches as soon as they become available to Jazz Pharmaceuticals (who are responsible for the packaging/distribution and allocation of worldwide product supply).</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-02-05T15:09:48.903Zmore like thismore than 2019-02-05T15:09:48.903Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1149298
star this property registered interest false more like this
star this property date less than 2019-10-15more like thismore than 2019-10-15
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Blood Cancer: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using genomics in healthcare for the diagnosis and treatment of blood cancers. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 569 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-22more like thismore than 2019-10-22
star this property answer text <p>Genomic testing is already in use as part of the diagnostic pathway for blood cancer. Through implementation of the NHS Genomic Medicine Service, NHS England and NHS Improvement are ensuring consistent and equitable access to genomic testing.</p><p> </p><p>The NHS Long Term Plan sets out the ambition to embed genomic medicine, including whole genome sequencing, into routine clinical care. It is expected that within the next year whole genome sequencing (WGS) will begin to be available for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p> </p> more like this
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
less than 2019-10-22T13:56:18.307Zmore like thismore than 2019-10-22T13:56:18.307Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1156063
star this property registered interest false more like this
star this property date less than 2019-10-24more like thismore than 2019-10-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Blood Cancer: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure that GPs follow NICE guidance on blood cancer. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 900212 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-10-30more like thismore than 2019-10-30
star this property answer text <p>The National Institute for Health and Care Excellence’s (NICE) clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although healthcare professionals are expected to take them fully into account</p><p><br>NICE’s updated referral guidelines for suspected cancer published in June 2015 could save about 5,000 lives a year, with general practitioners urged to think of cancer sooner and to lower the referral threshold for tests.</p> more like this
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property question first answered
less than 2019-10-30T07:32:29.153Zmore like thismore than 2019-10-30T07:32:29.153Z
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property previous answer version
2614
star this property answering member constituency Bury St Edmunds more like this
star this property answering member printed Jo Churchill more like this
star this property answering member
4380
star this property label Biography information for Jo Churchill more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1017502
star this property registered interest false more like this
star this property date less than 2018-11-30more like thismore than 2018-11-30
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what proportion of (a) leukaemia, (b) non-Hodgkin lymphoma, (c) Hodgkin lymphoma and (d) myeloma cases were diagnosed at each cancer stage in each of the last five years. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 197620 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-12-10more like thismore than 2018-12-10
star this property answer text <p>This information is not held centrally.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-12-10T15:38:39.683Zmore like thismore than 2018-12-10T15:38:39.683Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1060965
star this property registered interest false more like this
star this property date less than 2019-02-14more like thismore than 2019-02-14
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Counselling more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure that people with cancer are able to access psychological and emotional support. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 909320 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-02-19more like thismore than 2019-02-19
star this property answer text <p>By 2021, every person diagnosed with cancer will have access, where appropriate, to personalised care, including a needs assessment, a care plan and health and wellbeing information and support. The needs assessment guides a conversation about the person’s holistic needs (physical, psychosocial, financial and social) in order to identify any concerns, including psychological and emotional.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-02-19T17:25:31.79Zmore like thismore than 2019-02-19T17:25:31.79Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1128941
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much funding has been allocated to the Cancer Drugs Fund in each year since July 2016. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 259173 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>The Cancer Drugs Fund has had a fixed annual budget of £340 million for each year since July 2016.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T16:34:18.443Zmore like thismore than 2019-06-11T16:34:18.443Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1128942
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when the operational review of the Cancer Drugs Fund will be published. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 259174 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>An operational review of the Cancer Drugs Fund is currently underway and will be published this year.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T16:35:29.89Zmore like thismore than 2019-06-11T16:35:29.89Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1128943
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Cancer Drugs Fund in meeting the needs of people with rarer and less common cancers. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 259175 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>Following the reforms to the Cancer Drugs Fund (CDF) in July 2016 all new cancer drugs and significant new licensed indications for existing drugs are referred to the National Institute for Health and Care Excellence (NICE). This included the referral of all licensed cancer drug indications for rare cancers that had not previously been assessed by NICE.</p><p>This has led to an increase in the number, and proportion, of NICE appraisals of treatments for rare cancers. Since July 2016 21% or 24 out of 114 cancer drugs appraised by NICE have been for rarer cancers, compared to 9% or 18 out of 200, before the CDF reforms. Of these 24 drugs for rare cancers, 22 have been recommended for routine commissioning and two for use within the CDF. This shows that changes to the appraisal and funding of cancer drugs has led to an increase in the number of treatments for rare cancers both assessed by NICE and funded by NHS England in routine commissioning and via the CDF.</p><p> </p><p><strong> </strong></p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T16:52:17.36Zmore like thismore than 2019-06-11T16:52:17.36Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
1128940
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer: Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
unstar this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Cancer Strategy 2015-2020 remains a statement of current Government priorities in cancer care and treatment. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 259172 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>Government priorities for cancer care and treatment are set out in the NHS Long Term Plan, published in January this year. The NHS Long Term Plan builds on the Cancer Taskforce Report (2015), going further on its ambitions on survival and early diagnosis so that by 2028 we diagnose three-quarters of cancer patients at an early stage and see an extra 55,000 people each year survive cancer by five years or more following their diagnosis.</p><p> </p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T16:37:19.17Zmore like thismore than 2019-06-11T16:37:19.17Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this